| Diffuse Malignant Mesothelioma studied in …STUDIED_INderived19 of 19show fewer |
|---|
| → studied in | NCT01064648Phase 1/Phase 2 · active not recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05647265Phase 2 · recruiting Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (5 active) | — | — | Pleural Biphasic Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03228537Phase 1 · active not recruiting Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (5 active) | — | — | Biphasic Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 19 trials mapped (5 active) | — | — | Pleural Diffuse Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04158141Phase 3 · terminated Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (5 active) | — | — | Pleural Biphasic Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399371Phase 2 · completed Pembrolizumab in Treating Patients With Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (5 active) | — | — | Biphasic Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07121374Phase 1/Phase 2 · recruiting NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study · condition mapped ONTOLOGY_EXACT · 19 trials mapped (5 active) | — | — | Pleural Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034238Phase 1 · completed Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors · condition mapped ONTOLOGY_EXACT · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02672033NA · terminated Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (5 active) | — | — | Pleural Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00365053Phase 2 · completed PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery · condition mapped ALIAS · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243074Phase 2 · completed S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery · condition mapped ALIAS · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01861301Phase 2 · terminated Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309946Phase 2 · completed Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery · condition mapped ALIAS · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027703Phase 2 · completed Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma · condition mapped ALIAS · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01105390Phase 2 · withdrawn AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107432Phase 2 · completed Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. · condition mapped ALIAS · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039182Phase 2 · completed Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung · condition mapped ALIAS · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025207Phase 2 · completed Gefitinib in Treating Patients With Malignant Mesothelioma · condition mapped ALIAS · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00585845Phase 1 · terminated Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment · condition mapped ALIAS · 19 trials mapped (5 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |